Mesoblast Limited
MESO
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Profil
Biofarmaceutická společnost Mesoblast Limited vyvíjí a komercializuje alogenní buněčné léky ve Spojených státech, Austrálii, Singapuru, Velké Británii a Švýcarsku. Společnost nabízí produkty v oblasti kardiovaskulárních, páteřních ortopedických poruch, onkologie, hematologie a nemocí zprostředkovaných imunitním systémem a zánětlivých onemocnění. Její proprietární technologická platforma regenerativní medicíny je založena na specializovaných buňkách známých jako mezenchymální lineární buňky. Mezi produkty společnosti zařazené do klinických studií fáze III patří remestemcel-L pro léčbu akutního štěpu refrakterního na steroidy proti hostiteli, stejně jako syndrom akutní respirační tísně způsobený infekcí COVID-19; Rexlemestrocel-L pro léčbu pokročilého chronického srdečního selhání; a MPC-06-ID pro chronickou bolest dolní části zad způsobenou degenerativním onemocněním plotének. Vyvíjí se také MPC- 300-IV pro léčbu biologické refrakterní revmatoidní artritidy diabetické nefropatie. Společnost má strategické partnerství se společností Tasly Pharmaceutical Group, která nabízí MPC-150-IM pro srdeční selhání a MPC-25-IC pro srdeční infarkty v Číně; JCR Pharmaceuticals Co. Ltd. pro léčbu hojení ran u pacientů s epidermolýzou bullosa; a Grünenthal pro vývoj a komercializaci buněčné terapie pro léčbu chronické bolesti v dolní části zad. Společnost Mesoblast Limited byla založena v roce 2004 a má sídlo v australském Melbourne.
Sektor
Healthcare
Odvětví
Biotechnology
Počet zaměstnanců
73
Založení
2010-01-20
Podobné společnosti
$ 10.78
- $ 0.07
$ 32.15
+ $ 0.62
$ 35.12
+ $ 2.28
$ 26.00
- $ 1.80
$ 27.68
+ $ 0.24
$ 27.10
+ $ 1.01
$ 4.64
- $ 0.09
Zahraniční články
Výsledovka
Rozvaha
Peněžní toky
Výsledovka
Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
| Revenue | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 17.2 | 17.2 | 5.9 | 7.5 | 10.2 | 7.5 | 32.2 | 16.7 | 17.3 | 2.4 | 42.5 | 23.7 | 26.0 | 28.8 | 38.3 | 120.9 | 0.0 | |
| Cost of Revenues | 53.1 | 5.1 | 41.1 | 54.9 | 0.0 | 0.0 | 0.0 | 0.0 | 5.5 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Gross Profit | -35.9 | 12.1 | -35.2 | -47.4 | 10.2 | 7.5 | 32.2 | 16.7 | 11.8 | 2.4 | 42.5 | 23.7 | 26.0 | 28.8 | 38.3 | 120.9 | 0.0 |
| Revenue | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenues | 7.0 | 7.0 | 1.6 | 1.6 | 1.3 | 1.3 | 1.7 | 1.7 | 2.1 | 1.9 | |
| Cost of Revenues | 23.2 | 23.2 | 3.3 | 3.3 | 10.8 | 10.8 | 9.7 | 9.7 | 15.4 | 13.3 | |
| Gross Profit | -16.2 | -16.2 | -1.7 | -1.7 | -9.6 | -9.6 | -8.0 | -8.0 | -13.3 | -11.4 |
| Operating Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 27.2 | 32.8 | 53.0 | 56.2 | 59.8 | 65.9 | 58.9 | 50.0 | 77.6 | 55.3 | 43.1 | 36.9 | 15.3 | 7.6 | |
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 53.1 | 58.0 | 63.6 | 50.9 | 37.0 | 27.4 | 35.1 | 52.3 | 65.4 | 54.2 | 51.7 | 28.1 | 11.8 | 3.6 | |
| Depreciation & Amortization | 4.3 | 6.4 | 1.9 | 4.1 | 4.4 | 4.3 | 3.7 | 2.1 | 2.7 | 3.1 | 2.2 | 2.0 | 1.1 | 0.8 | 0.4 | 0.2 | 0.2 | |
| Total Operating Expenses | 74.1 | 74.5 | 49.0 | 76.8 | 90.8 | 115.1 | 107.6 | 97.9 | 92.0 | 92.5 | 98.4 | 137.1 | 98.4 | 88.9 | 65.0 | 27.2 | 11.1 | |
| Operating Income | -110.0 | -62.4 | -84.1 | -69.3 | -81.0 | -111.9 | -79.1 | -83.3 | -75.2 | -90.0 | -55.9 | -113.4 | -72.4 | -60.1 | -48.7 | 93.8 | -10.4 |
| Operating Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 6.7 | 7.1 | ||
| Selling General & Admin Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 14.4 | 12.7 | ||
| Depreciation & Amortization | 1.6 | 1.6 | 0.5 | 0.5 | 0.4 | 0.4 | 0.5 | 0.5 | 0.9 | 1.0 | ||
| Total Operating Expenses | 18.1 | 18.1 | 18.9 | 18.9 | 12.4 | 12.4 | 12.1 | 12.1 | 20.9 | 16.4 | ||
| Operating Income | -34.4 | -34.4 | -20.6 | -20.6 | -22.0 | -22.0 | -20.1 | -20.1 | -19.1 | -14.5 |
| Net Income | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | -7.5 | 3.6 | 1.8 | 0.8 | 0.0 | 0.0 | 0.5 | 0.7 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | |
| Interest Expense | 10.7 | 22.9 | 20.7 | 19.4 | 16.9 | 10.7 | 13.3 | 11.3 | 1.8 | 0.0 | 9.3 | 10.5 | 4.3 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Expense | 8.2 | -39.4 | -4.0 | -12.8 | -10.6 | 12.2 | -8.3 | -15.5 | 10.5 | -0.1 | -25.6 | 4.6 | -4.2 | 0.0 | -22.0 | -1.5 | -4.4 | |
| IBT | -101.8 | -101.8 | -88.1 | -82.1 | -91.6 | -99.6 | -87.4 | -98.8 | -66.0 | -90.2 | -90.8 | -119.4 | -81.0 | -60.1 | -48.7 | 92.2 | -14.8 | |
| Income Tax Expense | 0.3 | 0.3 | -0.2 | -0.2 | -0.2 | -0.8 | -9.4 | -9.0 | -30.7 | -13.4 | -86.7 | 6.1 | 0.0 | 1.6 | 22.4 | 1.6 | -0.7 | |
| Net Income | -102.1 | -102.1 | -88.0 | -81.9 | -91.3 | -98.8 | -77.9 | -89.8 | -35.3 | -76.8 | -4.1 | -119.4 | -81.0 | -61.7 | -71.1 | 90.6 | -14.8 |
| Net Income | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Interest Income | -3.8 | -3.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 4.3 | 4.9 | ||
| Interest Expense | 0.0 | 0.0 | 5.3 | 5.3 | 4.3 | 4.3 | 5.1 | 5.1 | 3.8 | 5.0 | ||
| Other Expense | 7.3 | 7.3 | -3.2 | -3.2 | -5.7 | -5.7 | 3.7 | 3.7 | -3.2 | -4.2 | ||
| IBT | -27.0 | -27.0 | -23.9 | -23.9 | -27.8 | -27.8 | -16.3 | -16.3 | -22.0 | -18.6 | ||
| Income Tax Expense | 0.1 | 0.1 | 0.1 | 0.1 | 0.0 | 0.0 | -0.1 | -0.1 | 0.0 | 0.0 | ||
| Net Income | -27.1 | -27.1 | -24.0 | -24.0 | -27.7 | -27.7 | -16.3 | -16.3 | -21.9 | -18.6 |
| Per Share Data | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $-0.11 | $-0.70 | $-0.83 | $-0.70 | $-0.90 | $-0.38 | $-0.96 | $-0.06 | $-1.84 | $-0.25 | $-0.20 | $-1.24 | $2.07 | $-0.52 | |
| EPS Diluted | $0.00 | $0.00 | $0.00 | $-0.11 | $-0.70 | $-0.83 | $-0.70 | $-0.90 | $-0.38 | $-0.96 | $-0.06 | $-1.84 | $-0.25 | $-0.20 | $-1.24 | $1.97 | $-0.52 | |
| Shares Outstanding | 127.3 | 120.8 | 98.7 | 739.0 | 129.8 | 119.1 | 112.1 | 99.9 | 93.1 | 79.8 | 72.8 | 64.8 | 319.3 | 310.4 | 57.1 | 43.8 | 28.4 | |
| Diluted Shares Outstanding | 127.3 | 120.8 | 98.7 | 739.0 | 129.8 | 119.1 | 112.1 | 99.9 | 93.1 | 79.9 | 72.8 | 64.8 | 319.4 | 310.5 | 57.1 | 46.0 | 28.4 |
| Per Share Data | TTM | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.03 | $-0.03 | ||
| EPS Diluted | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-0.03 | $-0.03 | ||
| Shares Outstanding | 127.3 | 127.3 | 114.1 | 114.1 | 112.2 | 112.2 | 85.1 | 85.1 | 786.6 | 735.2 | ||
| Diluted Shares Outstanding | 127.3 | 127.3 | 114.2 | 114.2 | 112.2 | 112.2 | 85.1 | 85.1 | 787.2 | 736.6 |
| Current Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 62.6 | 161.2 | 62.6 | 70.9 | 60.0 | 136.9 | 129.3 | 50.4 | 37.8 | 45.8 | 21.9 | 27.5 | 3.8 | 7.9 | 206.7 | 263.2 | 32.0 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Cash & ST Investments | 62.6 | 161.2 | 62.6 | 70.9 | 60.0 | 136.9 | 129.3 | 50.4 | 37.8 | 45.8 | 21.9 | 27.5 | 3.8 | 7.9 | 206.7 | 263.2 | 32.0 | |
| Accounts Receivable | 21.0 | 14.9 | 21.0 | 7.0 | 4.4 | 4.8 | 1.6 | 4.1 | 50.4 | 3.7 | 4.1 | 5.2 | 6.1 | 12.1 | 10.7 | 2.1 | 1.4 | |
| Inventory | 0.0 | 22.2 | 0.0 | 0.4 | 0.0 | -4.8 | -1.6 | -4.1 | -0.3 | 13.9 | 59.1 | 116.6 | 192.6 | 308.4 | 0.0 | 0.0 | 0.0 | |
| Other Current Assets | 0.0 | 6.1 | 2.9 | 2.9 | 5.4 | 11.3 | 7.2 | 12.1 | 13.2 | 0.3 | 3.8 | 10.1 | 1.3 | 3.5 | 0.3 | 0.2 | 0.1 | |
| Total Current Assets | 86.5 | 204.4 | 86.5 | 81.7 | 69.8 | 148.2 | 136.5 | 62.5 | 101.1 | 63.6 | 88.8 | 159.5 | 203.7 | 331.8 | 217.7 | 265.5 | 33.5 |
| Current Assets | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash And Equivalents | 161.2 | 38.0 | 38.0 | 62.6 | 63.0 | 77.1 | 77.6 | 70.9 | 48.4 | 67.2 | |
| Short Term Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | |
| Total Cash & ST Investments | 161.2 | 38.0 | 38.0 | 62.6 | 63.0 | 77.1 | 77.6 | 70.9 | 48.6 | 67.2 | |
| Accounts Receivable | 14.9 | 1.7 | 1.7 | 21.0 | 1.6 | 4.0 | 1.8 | 7.0 | 8.4 | 5.1 | |
| Inventory | 22.2 | 24.2 | 24.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.4 | 4.6 | 5.8 | |
| Other Current Assets | 6.1 | 5.8 | 5.8 | 2.9 | 21.9 | 4.0 | 5.8 | 2.9 | 4.2 | 5.4 | |
| Total Current Assets | 204.4 | 69.7 | 69.7 | 86.5 | 86.5 | 85.2 | 85.2 | 81.7 | 61.4 | 78.1 |
| Long-Term Assets | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 3.8 | 5.8 | 3.8 | 6.5 | 10.0 | 12.1 | 10.3 | 0.8 | 1.1 | 1.8 | 3.1 | 5.7 | 4.7 | 2.8 | 2.0 | 0.6 | 0.2 | |
| Goodwill | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 175.1 | 140.5 | 127.7 | 116.2 | 109.7 | 0.0 | |
| Intangible Assets | 441.3 | 437.4 | 441.3 | 442.7 | 444.2 | 446.1 | 447.1 | 448.7 | 450.2 | 451.9 | 453.4 | 671.6 | 547.4 | 420.1 | 381.0 | 365.6 | 0.4 | |
| Long-Term Investments | 1.0 | 1.4 | 1.0 | 1.8 | 1.8 | 2.1 | 1.9 | 2.3 | 2.3 | 2.0 | 2.0 | 3.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.3 | |
| Other Long-Term Assets | 0.5 | 1.3 | 2.1 | 0.5 | 1.9 | 1.7 | 3.3 | 3.3 | 3.4 | 1.9 | 2.3 | 3.1 | 3.0 | 1.3 | 0.0 | 0.0 | 0.0 | |
| Total Long-Term Assets | 582.7 | 580.3 | 582.7 | 587.8 | 592.3 | 596.5 | 597.1 | 589.6 | 591.4 | 592.1 | 595.2 | 858.5 | 695.6 | 551.9 | 502.7 | 497.8 | 6.0 | |
| Total Assets | 669.2 | 784.7 | 669.2 | 669.4 | 662.1 | 744.7 | 733.6 | 652.1 | 692.4 | 655.7 | 684.0 | 1,017.9 | 899.3 | 883.7 | 720.5 | 763.3 | 39.5 |
| Long-Term Assets | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Property, Plant & Equipment | 5.8 | 6.2 | 6.2 | 3.8 | 3.8 | 5.5 | 5.5 | 6.5 | 7.1 | 8.2 | |
| Goodwill | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | 134.5 | |
| Intangible Assets | 437.4 | 440.4 | 440.4 | 441.3 | 441.3 | 442.1 | 442.1 | 442.7 | 443.1 | 443.4 | |
| Long-Term Investments | 1.4 | 1.2 | 1.2 | 1.0 | 1.0 | 0.8 | 0.8 | 1.8 | 2.0 | 1.9 | |
| Other Long-Term Assets | 1.3 | 1.3 | 1.3 | 2.1 | 2.1 | 2.2 | 2.2 | 0.5 | 2.4 | 1.9 | |
| Total Long-Term Assets | 580.3 | 583.6 | 583.6 | 582.7 | 582.7 | 585.1 | 585.1 | 587.8 | 589.1 | 589.9 | |
| Total Assets | 784.7 | 653.3 | 653.3 | 669.2 | 669.2 | 670.3 | 670.3 | 669.4 | 650.4 | 668.1 |
| Current Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.1 | 19.1 | 7.1 | 20.1 | 23.1 | 19.6 | 25.0 | 13.1 | 18.9 | 21.8 | 27.2 | 36.8 | 20.7 | 20.8 | 11.6 | 3.0 | 1.1 | |
| Short-Term Debt | 16.5 | 56.8 | 16.5 | 10.0 | 8.2 | 56.0 | 36.0 | 14.0 | 0.0 | 0.0 | 0.0 | 0.0 | 5.7 | 0.0 | 3.3 | 0.0 | 0.0 | |
| Other Current Liabilities | 4.6 | 26.7 | 49.7 | 5.4 | 20.1 | 18.7 | 29.2 | 17.3 | 5.1 | 14.9 | 2.3 | 6.7 | 0.3 | 13.6 | 1.4 | 0.6 | 0.5 | |
| Current Liabilities | 73.2 | 102.6 | 73.2 | 42.0 | 51.4 | 94.3 | 90.1 | 44.3 | 24.0 | 36.7 | 29.4 | 63.0 | 42.7 | 50.6 | 44.5 | 30.8 | 1.6 |
| Current Liabilities | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 19.1 | 11.9 | 11.9 | 7.1 | 7.1 | 10.8 | 0.0 | 20.1 | 21.0 | 23.0 | |
| Short-Term Debt | 56.8 | 19.9 | 19.9 | 16.5 | 16.5 | 11.4 | 8.5 | 10.0 | 10.9 | 9.8 | |
| Other Current Liabilities | 26.7 | 41.0 | 41.0 | 49.7 | 49.7 | 1.0 | 12.1 | 5.4 | 22.0 | 21.8 | |
| Current Liabilities | 102.6 | 72.8 | 72.8 | 73.2 | 73.2 | 31.4 | 31.4 | 42.0 | 53.9 | 54.6 |
| Long-Term Liabilities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 102.4 | 71.3 | 102.4 | 106.5 | 98.7 | 49.5 | 63.3 | 67.3 | 59.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Capital Leases | 4.6 | 6.3 | 4.6 | 7.7 | 10.3 | 11.3 | 9.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.7 | 11.1 | 20.1 | 49.3 | 62.7 | 194.5 | 158.6 | 146.0 | 132.9 | 127.8 | 0.0 | |
| Total Liabilities | 188.8 | 187.2 | 188.8 | 167.6 | 165.1 | 163.3 | 184.3 | 171.1 | 146.4 | 138.9 | 155.9 | 408.6 | 327.6 | 253.4 | 241.6 | 247.4 | 1.6 |
| Long-Term Liabilities | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Long-Term Debt | 71.3 | 106.2 | 106.2 | 102.4 | 102.4 | 110.6 | 110.6 | 106.5 | 103.7 | 102.0 | |
| Capital Leases | 6.3 | 7.1 | 7.1 | 4.6 | 4.6 | 6.2 | 6.2 | 7.7 | 8.3 | 8.9 | |
| Def. Tax Liability | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Total Liabilities | 187.2 | 192.1 | 192.1 | 188.8 | 188.8 | 161.6 | 161.6 | 167.6 | 168.3 | 168.1 |
| Total Common Equity | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1,310.8 | 1,508.8 | 1,310.8 | 1,249.1 | 1,165.3 | 1,163.2 | 1,051.5 | 910.4 | 889.5 | 830.4 | 770.3 | 737.3 | 677.1 | 654.5 | 0.0 | 0.0 | 0.0 | |
| Retained Earnings | -908.8 | -1,010.9 | -908.8 | -820.8 | -738.9 | -647.6 | -548.8 | -470.0 | -380.2 | -344.9 | -268.1 | -298.2 | -178.8 | -97.8 | -36.2 | 35.0 | -55.6 | |
| Comprehensive Income | 78.3 | 99.5 | 78.3 | 73.5 | 70.7 | 65.8 | 46.6 | 40.6 | 36.7 | 31.2 | 26.0 | 170.3 | 73.4 | 73.6 | 30.0 | 3.7 | 5.6 | |
| Total Common Equity | 480.4 | 597.4 | 480.4 | 501.8 | 497.0 | 581.4 | 549.3 | 481.1 | 546.0 | 516.8 | 528.2 | 609.4 | 571.7 | 630.3 | 478.8 | 515.8 | 37.9 |
| Total Common Equity | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | 1,508.8 | 1,320.2 | 1,320.2 | 1,310.8 | 1,310.8 | 1,286.2 | 1,286.2 | 1,249.1 | 1,207.5 | 1,207.7 | |
| Retained Earnings | -1,010.9 | -956.7 | -956.7 | -908.8 | -908.8 | -853.3 | -853.3 | -820.8 | -798.9 | -780.3 | |
| Comprehensive Income | 99.5 | 97.8 | 97.8 | 78.3 | 78.3 | 75.8 | 75.8 | 73.5 | 73.6 | 72.6 | |
| Total Common Equity | 597.4 | 461.3 | 461.3 | 480.4 | 480.4 | 508.7 | 508.7 | 501.8 | 482.2 | 500.0 |
| Other | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 118.9 | 128.2 | 118.9 | 116.5 | 106.9 | 105.5 | 99.3 | 81.3 | 59.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 480.4 | 597.4 | 480.4 | 501.8 | 497.0 | 581.4 | 549.3 | 481.1 | 546.0 | 516.8 | 528.2 | 609.4 | 571.7 | 630.3 | 478.8 | 515.8 | 37.9 |
| Other | 4-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | 4-2023 | 3-2023 | 2-2023 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Book Value | 597.4 | 461.3 | 461.3 | 480.4 | 480.4 | 508.7 | 508.7 | 501.8 | 482.2 | 500.0 |
| Cash Flow From Operating Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -32.5 | -102.1 | -88.0 | -81.9 | -91.3 | -98.8 | -77.9 | -89.8 | -35.3 | -76.8 | -4.1 | -119.4 | -81.0 | -61.7 | -71.1 | 90.6 | -14.8 | |
| Depreciation & Amortization | 2.4 | 6.4 | 4.7 | 4.1 | 4.4 | 4.3 | 3.7 | 2.1 | 2.7 | 3.1 | 2.2 | 2.0 | 1.1 | 0.8 | 0.4 | 0.2 | 0.2 | |
| Stock-Based Compensation | 2.2 | 22.1 | 5.9 | 3.7 | 5.5 | 12.5 | 7.5 | 4.4 | 6.2 | 5.3 | 3.4 | 8.6 | 9.4 | 12.3 | 12.1 | 3.3 | 1.0 | |
| Change Working Capital | 3.8 | -3.0 | -2.6 | -2.5 | 4.9 | -8.4 | 13.3 | 20.4 | -8.9 | -13.8 | -0.1 | 5.3 | -0.9 | -7.2 | -0.3 | 117.0 | 0.3 | |
| Change In Accounts Receivable | 2.1 | 6.3 | -15.5 | -0.1 | 0.1 | -1.7 | 0.9 | 5.0 | -6.1 | -0.9 | -0.5 | 0.3 | 2.6 | 2.1 | 0.0 | 0.0 | 0.0 | |
| Change In Accounts Payable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 10.0 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | 0.0 | 0.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.1 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -2.4 | 26.4 | 31.8 | 13.5 | 11.0 | -15.4 | 6.5 | 14.0 | -9.0 | 0.2 | -2.6 | -5.0 | -12.1 | -3.3 | 12.1 | 3.3 | 1.0 | |
| Cash from Operations | -27.5 | 0.0 | 0.0 | -63.3 | -65.8 | -106.7 | -56.4 | -57.8 | -75.0 | -95.5 | -88.0 | -121.7 | -81.9 | -54.1 | -72.1 | 108.2 | -9.7 |
| Cash Flow From Operating Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | 0.0 | 0.0 | -27.1 | 0.0 | -24.0 | 0.0 | 0.0 | 0.0 | -16.3 | -16.3 | |
| Depreciation & Amortization | 0.0 | 0.0 | 2.2 | 0.0 | 1.0 | 0.0 | 0.0 | 0.0 | 1.2 | 1.2 | |
| Stock-Based Compensation | 0.0 | 0.0 | 3.5 | 0.0 | 7.6 | 0.0 | 0.0 | 0.0 | 1.1 | 1.1 | |
| Change Working Capital | 0.0 | 0.0 | -5.3 | 0.0 | -2.8 | 0.0 | 0.0 | 0.0 | 1.9 | 1.9 | |
| Change In Accounts Receivable | 0.0 | 0.0 | -6.3 | 0.0 | 8.8 | 0.0 | 0.0 | 0.0 | 1.0 | 1.0 | |
| Change In Accounts Payable | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Change In Inventories | 0.0 | 0.0 | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Non-cash Items | -15.6 | -14.9 | 10.2 | -12.7 | 7.9 | -10.3 | 0.0 | 0.0 | -1.2 | -1.2 | |
| Cash from Operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Investing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.3 | -0.7 | -0.3 | -0.3 | -0.2 | -1.6 | -2.2 | -0.3 | -0.2 | -0.3 | -0.9 | -2.7 | -37.9 | -2.8 | -2.7 | -0.5 | -0.1 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -1.0 | -0.7 | -1.0 | 0.0 | 0.0 | -2.3 | 0.0 | 0.0 | 0.0 | 3.4 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.8 | -0.9 | -1.5 | -2.2 | -1.3 | 0.0 | 0.0 | |
| Sales of Investment | 0.2 | 0.2 | 0.2 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.2 | 0.0 | 0.0 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.5 | 0.0 | 0.6 | -1.4 | 0.0 | 9.3 | 1.7 | -0.3 | |
| Cash from Investing | -0.1 | 0.0 | 0.0 | -0.2 | -0.2 | -1.6 | -3.3 | -1.0 | -1.2 | 0.1 | -1.7 | -5.6 | -40.8 | -5.0 | 5.3 | 4.7 | -0.3 |
| Cash Flow From Investing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Capital Expenditure | -0.1 | -0.3 | -0.5 | -0.1 | -0.1 | 0.0 | 0.0 | 0.0 | 0.0 | -0.2 | |
| Acquisitions | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Investments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Sales of Investment | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | 0.2 | 0.0 | 0.0 | 0.0 | |
| Other Investing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Investing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash Flow From Financing Activities | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | -13.5 | 0.0 | 0.0 | -2.7 | -58.2 | -2.9 | -2.1 | 0.0 | -0.4 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 259.9 | 9.2 | 2.4 | 12.2 | 59.7 | 9.1 | 20.2 | 21.9 | 59.8 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Issuance of Common Stock | 65.4 | 0.0 | 0.0 | 88.6 | 0.2 | 106.3 | 144.9 | 30.3 | 40.6 | 61.9 | 68.5 | 60.0 | 2.5 | 174.9 | 4.9 | 126.9 | 26.8 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | -7.3 | 0.0 | 0.0 | -11.5 | 48.2 | 11.1 | -5.8 | 41.4 | 28.4 | -1.9 | -6.5 | -0.6 | 0.0 | -5.5 | 0.0 | -0.8 | -1.3 | |
| Cash from Financing | 40.3 | 0.0 | 0.0 | 74.5 | -9.9 | 114.5 | 137.0 | 71.6 | 68.6 | 60.0 | 62.1 | 59.4 | 2.4 | 169.3 | 4.9 | 126.1 | 25.5 |
| Cash Flow From Financing Activities | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt Repaid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Debt Issued | 0.0 | 128.2 | 128.2 | 126.1 | 126.1 | 7.2 | 118.9 | -3.1 | 2.9 | 2.7 | |
| Issuance of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Repurchase of Common Stock | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Dividends Paid | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Other Financing Activities | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Cash from Financing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -8.4 | 98.6 | -8.4 | 10.9 | -76.4 | 7.6 | 78.9 | 12.7 | -8.0 | -35.2 | -29.8 | -52.3 | -118.9 | 109.7 | -56.5 | 231.2 | 15.5 | |
| Closing Cash Balance | 63.0 | 161.6 | 63.0 | 71.3 | 60.4 | 136.9 | 129.3 | 50.4 | 37.8 | 45.8 | 80.9 | 144.1 | 196.4 | 315.3 | 206.7 | 263.2 | 32.0 |
| Cash position | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Change in Cash | -14.7 | -16.8 | -20.5 | 144.0 | -13.1 | -11.8 | -13.4 | -1.2 | 24.4 | -18.1 | |
| Closing Cash Balance | 130.0 | 144.7 | 161.6 | 182.1 | 38.0 | 51.1 | 63.0 | 76.4 | 77.6 | 53.2 |
| Free Cash Flow | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -27.9 | -50.7 | -48.8 | -63.6 | -66.0 | -108.3 | -58.6 | -58.1 | -75.2 | -95.8 | -88.9 | -124.4 | -119.8 | -56.9 | -74.8 | 107.8 | -9.7 | |
| Real Free Cash Flow | -30.1 | -72.8 | -54.7 | -67.2 | -71.6 | -120.8 | -66.1 | -62.4 | -81.4 | -101.1 | -92.3 | -133.0 | -129.2 | -69.2 | -86.9 | 104.5 | -10.8 |
| Free Cash Flow | 2-2026 | 1-2026 | 4-2025 | 3-2025 | 2-2025 | 1-2025 | 4-2024 | 3-2024 | 2-2024 | 1-2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -15.7 | -15.3 | -14.9 | -12.8 | -10.4 | -10.4 | -0.1 | 0.0 | -13.3 | -14.4 | |
| Real Free Cash Flow | -15.7 | -15.3 | -18.4 | -12.8 | -18.0 | -10.4 | -0.1 | 0.0 | -14.4 | -15.5 |
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní
Nacenění
| Ukazatel | Aktuální | Historické | Konkurence |
|---|---|---|---|
| P/E | -21.1 | -72 | -1.4 |
| P/S | 125 | 379.7 | 9.4 |
| P/B | 3.6 | 5.8 | 5.2 |
| P/FCF | -36 | -66.4 | -1.5 |
| Market cap | $1.9 | $2.4 |
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.
Finance
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Debt to Assets | 16.3 % | 9.2 % | 0 % |
| Debt to Income | -125.5 % | -77.2 % | 0 % |
| Debt to Free cash flow | -206.2 % | -49.4 % | 0 % |
| Interest expense percentage | -9.7 % | -12.7 % | 44.7 % |
| Current ratio | 2 | 1.9 | 0 |
Efektivita
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| ROE | -17.1 % | -13 % | 0 % |
| ROA | -13 % | -9.6 % | 0 % |
| CapEx to Revenue | 3.9 % | 5.2 % | 0 % |
| RaD to Revenue | 0 % | 424.9 % | 0 % |
| ROEM | 212,321.0 | 175615.9 |
Marže
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Gross margin | -208.5 % | 14.7 % | 68.7 % |
| Operating margin | -639.5 % | -787.2 % | 35.5 % |
| Net margin | -593.9 % | -761.1 % | 9.5 % |
Dividenda
| Ukazatel | Aktuální | Historické | Srovnání |
|---|---|---|---|
| Dividend yield | 0 % | 0 % | 0 % |
| Dividend payout percentage | 0 % | 0 % | 0 % |
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.
Ostatní
| Ukazatel | Aktuální | Historické |
|---|---|---|
| Shares outstanding | 127.3 mil | 160.8 mil |
| Employee count | 0.1 tis | 0.1 tis |
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
Placený obsah
Pro přístup na tuto stránku budete potřebovat placené členství.
Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.
